Low antibody levels against cell wall - Attached proteins of Streptococcus pyogenes predispose for severe invasive disease

Journal of Infectious Diseases

Volumn 189, Issue 5, 2004, Pages 797-804

  Åkesson, Per ^a   Rasmussen, Magnus ^a   Mascini, Ellen ^c   Von Pawel Rammingen, Ulrich ^a   Janulczyk, Robert ^a   Collin, Mattias ^a   Olsén, Arne ^b   Mattsson, Eva ^a   Olsson, Martin L ^a   Björck, Lars ^a   Christensson, Bertil ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; ENDOS ANTIGEN; GRAB ANTIGEN; IDES ANTIGEN; IMMUNOGLOBULIN G; MTSA ANTIGEN; SCLA ANTIGEN; SCLB ANTIGEN; SPEB ANTIGEN; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL ADHESION; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; STREPTOCOCCAL TOXIC SHOCK SYNDROME; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTIBODIES, BACTERIAL; BACTERIAL ADHESION; BACTERIAL TYPING TECHNIQUES; CELL WALL; FASCIITIS, NECROTIZING; HUMANS; PHYLOGENY; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 12144289327     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/381982     Document Type: Article

References (32)

1. Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000; 51:271-88.
2. Musser JM, Krause RM. The revival of group A streptococcal diseases with a commentary on staphylococcal toxic shock syndrome. In: Krause RM, Fauci A, eds. Emerging infections. New York: Academic Press, 1998:185-218.
3. Ho PL, Johnson DR, Yue AW, et al. Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J Clin Microbiol 2003; 41:937-42.
4. Muller MP, Low DE, Green KA, et al. Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003; 163:467-72.
5. Sharkawy A, Low DE, Saginur R, et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
6. 2-macroglobulin. J Biol Chem 1999; 274:15336-44.
7. Lukomski S, Nakashima K, Abdi I, et al. Identification and characterization of the scl gene encoding a group A streptococcus extracellular protein virulence factor with similarity to human collagen. Infect Immun 2000; 68:6542-53.
8. Rasmussen M, Eden A, Björck L. SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect Immun 2000; 68:6370-7.
9. Lukomski S, Nakashima K, Abdi I, et al. Identification and characterization of a second extracellular collagen-like protein made by group A streptococcus: control of production at the level of translation. Infect Immun 2001; 69:1729-38.
10. Rasmussen M, Björck L. Unique regulation of SclB - a novel collagen-like surface protein of Streptococcus pyogenes. Mol Microbiol 2001; 40:1427-38.
11. Whatmore AM. Streptococcus pyogenes sclB encodes a putative hyper-variable surface protein with a collagen-like repetitive structure. Microbiology 2001; 147:419-29.
12. Janulczyk R, Pallon J, Björck L. Identification and characterization of a Streptococcus pyogenes ABC transporter with multiple specificity for metal cations. Mol Microbiol 1999; 34:596-606.
13. Ricci S, Janulczyk R, Björck L. The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect Immun 2002; 70:4968-76.
14. Collin M, Olsen A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001; 20:3046-55.
15. Collin M, Olsen A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 2001; 69:7187-9.
16. von Pawel-Rammingen U, Johansson BP, Björck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002; 21:1607-15.
17. Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsen A. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin- mediated opsonophagocytosis. Infect Immun 2002; 70:6646-51.
18. von Pawel-Rammingen U, Johansson BP, Tapper H, Björck L. Mac/IdeS, a cysteine proteinase of Streptococcus pyogenes, protects the pathogen from phagocytic killing. Nat Med 2002; 8:1044-5.
19. Mascini EM, Jansze M, Schellekens JF, et al. Invasive group A streptococcal disease in The Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 2000; 181:631-8.
20. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 1993; 269:390-1.
21. Beall B, Facklam R, Hoenes T, Schwartz B. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol 1997; 35:1231-5.
22. Gerlach D, Knoll H, Köhler W, Ozegowski JH, Hribalova V. Isolation and characterization of erythrogenic toxins V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983; 255:221-33.
23. Berge A, Björck L. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995; 270:9862-7.
24. Basma H, Norrby-Teglund A, Guedez Y, et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999; 67:1871-7.
25. Holm SE, Norrby A, Bergholm A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden 1988-1989. J Infect Dis 1992; 166:31-7.
26. Eriksson BK, Andersson J, Holm SE, Norgren M. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 1999; 180:410-8.
27. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39:165-78.
28. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-71.
29. Christensson B, Fehrenbach FJ, Hedström SÅ. A new serological assay for Staphylococcus aureus infections: IgG antibodies to S. aureus lipase using enzyme-linked immunosorbent assay. J Infect Dis 1985; 152:286-92.
30. Christensson B, Boutonnier A, Ryding U, Fournier J-M. Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8. J Infect Dis 1991; 163:530-3.
31. Rasmussen M, Björck L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 2002; 43:537-44.
32. Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of group A streptococcal infections. Nat Med 2002; 8:1398-404.